(Q27684731)
Statements
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation (English)
0 references
1 July 2013
0 references
23
0 references
3741-8
0 references
13
0 references